Pitcairn CO Supernus Pharmaceuticals, Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pitcairn CO holds 8,818 shares of SUPN stock, worth $318,682. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,818

Previous 9,851 10.49%

Holding current value

$318,682

Previous $263,000 4.18%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$25.77 - $35.16 $26,620 - $36,320	-1,033 Reduced 10.49%	8,818 $274,000
Q2 2024 Aug 13, 2024	BUY	$25.99 - $33.85 $17,361 - $22,611	668 Added 7.27%	9,851 $263,000
Q1 2024 May 13, 2024	BUY	$27.11 - $35.17 $2,954 - $3,833	109 Added 1.2%	9,183 $313,000
Q4 2023 Feb 14, 2024	SELL	$22.72 - $29.68 $1,704 - $2,226	-75 Reduced 0.82%	9,074 $262,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $14,363 - $17,146	521 Added 6.04%	9,149 $252,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $1,914 - $2,478	-64 Reduced 0.74%	8,628 $259,000
Q1 2023 May 05, 2023	SELL	$34.93 - $42.03 $6,147 - $7,397	-176 Reduced 1.98%	8,692 $314,000
Q4 2022 Feb 13, 2023	SELL	$31.09 - $37.88 $10,352 - $12,614	-333 Reduced 3.62%	8,868 $316,000
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $4,318 - $5,311	150 Added 1.66%	9,201 $311,000
Q2 2022 Aug 12, 2022	BUY	$25.33 - $34.25 $1,317 - $1,781	52 Added 0.58%	9,051 $262,000
Q1 2022 May 12, 2022	BUY	$28.51 - $32.9 $14,910 - $17,206	523 Added 6.17%	8,999 $291,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $223,512 - $290,048	8,476 New	8,476 $247,000
Q3 2018 Nov 02, 2018	SELL	$42.7 - $56.55 $347,492 - $460,203	-8,138 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$44.1 - $59.85 $31,928 - $43,331	-724 Reduced 8.17%	8,138 $487,000
Q1 2018 May 11, 2018	BUY	$37.15 - $46.9 $14,562 - $18,384	392 Added 4.63%	8,862 $406,000
Q4 2017 Feb 13, 2018	BUY	$36.4 - $42.6 $9,937 - $11,629	273 Added 3.33%	8,470 $337,000
Q3 2017 Nov 03, 2017	BUY	$36.75 - $49.65 $301,239 - $406,981	8,197	8,197 $328,000

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account